Efficacy and tolerance of an emollient+ on babies and children with Atopic Dermatitis: an observational study

A. Patsatsi, S. Salah, A.-L. Demessant Flavigny, D. Kerob

  • 10min
  • Jul. 2023
  • Supported by
  • La Roche-Posay

25WCD2023_IMG


INTRODUCTION


Atopic dermatitis (AD) is one of the most prevalent inflammatory skin diseases, preferentially affecting children, with flares of inflammatory lesions and a permanent background of skin dryness. It is associated with itchy, red, swollen plaques and dry, cracked skin. This is a chronic condition where emollients, and Emollients+ are the foundation of treatment. Anti-inflammatory drugs (topicals/systemics) are recommended based on the severity of atopic dermatitis. One of the most documented consequences of AD on babies and children is a decrease in quality of sleep, this could lead, in the growing child, to difficulties in managing emotions and behavioral problems.